Cortez, Keziah J.
HRN: 07-14-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2025
CEFUROXIME 1.5GM (VIAL)
07/16/2025
07/23/2025
IVT
1.5g
Q8
Transected Patellar Tendon
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines